Patents Assigned to DR. WILLMAR SCHWABE GMBH & CO., KG
  • Publication number: 20220080006
    Abstract: A process prepares a rapidly disintegrating tablet with a disintegration time of at most 15 minutes for the peroral administration of a dry extract of the leaves of Ginkgo biloba, and with a total weight of the tablet of between 150 mg and 300 mg per 100 mg of ginkgo extract contained. Rapidly disintegrating tablets containing dry extract of the leaves of Ginkgo biloba can be prepared, which, due to their smaller dimensions, are easier to take than the tablets used hitherto. In a preferred form, the tablets do not contain lactose and are therefore also well tolerated.
    Type: Application
    Filed: January 8, 2020
    Publication date: March 17, 2022
    Applicant: DR. WILLMAR SCHWABE GMBH & CO. KG
    Inventors: Joachim HERRMANN, Andreas Rothe
  • Patent number: 10357530
    Abstract: The present invention relates to a combination of valerian root extract and lavender oil treating of sleep disorders, as well as to a combination of preparation comprising valerian root extract and lavender oil.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: July 23, 2019
    Assignee: Dr. Willmar Schwabe GmbH & Co. KG
    Inventors: Wilfried Dimpfel, Michael Nöldner
  • Patent number: 10028986
    Abstract: The present invention relates to an improved multistep method for the production of an extract of Ginkgo biloba leaves for use as a drug.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: July 24, 2018
    Assignee: Dr. Willmar Schwabe GMBH & Co., KG
    Inventors: Frank Waimer, Steffen Reinhard, Hermann Hauer
  • Patent number: 9592261
    Abstract: The invention relates to a plant extract combination of ginkgo and ginseng which is effective especially in a (synergistic) over-additive manner and optionally comprises whitethorn extract. Ginseng is used in the form of an ethanol/ethanol/water extract while ginkgo is used in the form of an acetone/acetone-water extract, for example, and the active extracts are prepared at specific quantitative ratios, particularly <1.1:1, thus unexpectedly boosting the prevention or also the treatment of a decline in the mental capacity related to age or also other disorders.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: March 14, 2017
    Assignee: Dr. Willmar Schwabe GmbH & Co. KG
    Inventors: Rolf D. Beutler, Karlheinz Schmidt
  • Patent number: 8642099
    Abstract: The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, which is obtainable by the method according to the present invention, as well as to its use.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: February 4, 2014
    Assignee: Dr. Willmar Schwabe GmbH & Co. KG
    Inventors: Clemens Erdelmeier, Hermann Hauer, Egon Koch, Friedrich Lang
  • Publication number: 20100310653
    Abstract: The present invention relates to the use of an extract made of leaves of Ginkgo biloba for the production of a preparation, or an extract made of leaves of Ginkgo biloba as an agent for the treatment and prophylaxis of the dementia syndrome, the early stages and pre-stages thereof, wherein 180 to 300 mg of Ginkgo extract is administered once a day.
    Type: Application
    Filed: December 18, 2008
    Publication date: December 9, 2010
    Applicant: DR. WILLMAR SCHWABE GMBH & CO. KG
    Inventors: Joachim Herrmann, Robert Hörr
  • Publication number: 20100112096
    Abstract: The invention relates to production methods for obtaining dry extracts from Pelargonium sidoides and/or Pelargonium reniforme, extracts which may be obtained according to said method, and pharmaceutical products comprising such extracts.
    Type: Application
    Filed: April 4, 2008
    Publication date: May 6, 2010
    Applicant: DR. WILLMAR SCHWABE GMBH & CO., KG
    Inventors: Joachim Herrmann, Marc Thöle
  • Publication number: 20090142428
    Abstract: The present invention relates to extracts from the bark of corynanthe species, in particular corynanthe pachyceras as well as to their use for the therapy and prophylaxis of diseases of the lower urinary tract, sexual disorders, lipid metabolism disorders, cardiovascular diseases and acute and chronic pain conditions. The present invention further relates to medicaments, dietetic food products and pharmaceutical preparations containing these extracts.
    Type: Application
    Filed: November 7, 2006
    Publication date: June 4, 2009
    Applicant: DR. WILLMAR SCHWABE GMBH & CO. KG
    Inventors: Egon Koch, Hermann Hauer
  • Publication number: 20080020068
    Abstract: The present invention relates to the use of trisubstituted benzopyranones for the treatment or propylaxis of pathological conditions associated with oxidative stress and/or inflammatory reactions as well as to novel trisubstituted benzopyranones and the physiologically acceptable salts thereof. The present invention further relates to plant extracts, medicaments, dietetic food products and pharmaceutical preparations containing these compounds.
    Type: Application
    Filed: June 30, 2005
    Publication date: January 24, 2008
    Applicant: Dr.Willmar Schwabe GmbH & Co. KG
    Inventors: Stefan Germer, Hermann Hauer, Egon Koch, Karl Schotz